Afib, Stroke, and the New Anticoagulants, a Roundtable
Thu, Mar 22nd 2012
Medpagetoday.com
The arrival of dabigatran and rivaroxaban on the U.S. market, as well as the impending FDA approval of apixaban, changes the landscape of stroke prevention in atrial fibrillation.
Read more